Ildong Pharmaceutical Co., Ltd.

KSE 249420.KS

Ildong Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD 44.66 M

Ildong Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities is USD 44.66 M for the year ending December 31, 2023, a 1,819.79% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • Ildong Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD -2.60 M, a -102.97% change year over year.
  • Ildong Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD 87.31 M, a 2,178.65% change year over year.
  • Ildong Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD -4.20 M, a 63.86% change year over year.
  • Ildong Pharmaceutical Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD -11.62 M, a -64.34% change year over year.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
Loading...
SV Wall Street
KSE: 249420.KS

Ildong Pharmaceutical Co., Ltd.

CEO Yun Paul Woongsup
IPO Date Aug. 31, 2016
Location South Korea
Headquarters 2, Baumoe-ro 27-gil
Employees 1,020
Sector Consumers Staples
Industries
Description

Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-histamine drugs, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, topical preparation, and urogenital system applications. It also provides raw material drugs; health foods and foods; cosmetics; medical devices for scar treatment; and other drugs for treating thick wounds, osteoarthritis, periarthritis of shoulder, and artificial tears, as well as feminine cleanser products. In addition, the company manages licenses and provides contract manufacturing services. It also exports its products to approximately 20 countries worldwide. Ildong Pharmaceutical Co., Ltd. a strategic collaboration with Evotec SE to accelerate the development of various Ildong's proprietary projects through access to Evotec's INDiGO platform. The company was founded in 1941 and is headquartered in Seoul, South Korea.

Similar companies

185750.KS

Chong Kun Dang Pharmaceutical Corp.

USD 56.39

-4.53%

000100.KS

Yuhan Corporation

USD 83.97

-5.00%

128940.KS

Hanmi Pharm. Co., Ltd.

USD 159.35

-4.24%

003850.KS

Boryung Corporation

USD 6.82

-1.91%

069620.KS

Daewoong pharmaceutical Co.,Ltd

USD 89.76

-4.42%

StockViz Staff

February 4, 2025

Any question? Send us an email